Insulin Resistance and Parkinson's Disease: New Insights
Study links insulin resistance to worsened Parkinson's symptoms and neuron health.
― 6 min read
Table of Contents
Parkinson’s disease (PD) is one of the most common nervous system disorders. It affects movement and mental function because it involves the gradual loss of brain cells that make dopamine, a chemical important for controlling movement. Most cases occur without a known cause, but age, environmental factors, and genetic conditions can all play a role. Recent studies have shown that people with Type 2 Diabetes (T2D) have a 30 to 40% higher chance of developing PD.
When someone has both PD and diabetes, they often experience worse symptoms, including problems with movement and thinking. Researchers are looking into how T2D and PD might be connected at a biological level. They suspect that both conditions might share some common problems in the body. For example, Insulin Resistance, a condition where the body does not respond properly to insulin, is seen in people with both T2D and PD. Insulin is crucial because it helps cells use sugar for energy, and without it, brain cells may struggle to survive and function well.
In this study, researchers wanted to look at how insulin resistance could affect healthy brain cells and potentially lead to PD. They used a type of brain cell made from skin cells (known as induced pluripotent stem cells) to create mini-brains, called organoids, in the lab. These organoids were made from healthy individuals.
Investigating Insulin's Role in Brain Health
The research focused on how different levels of insulin in the environment affect these mini-brains. The scientists compared conditions with high insulin levels-similar to those seen in T2D-to a lower, more normal level of insulin. They found the average insulin level in the standard media was much higher than what would normally be found in the brain.
To test their hypothesis, they created a special media with less insulin. They confirmed this lower insulin level did not harm the growth or health of the mini-brains. They also looked at specific cells known as Dopaminergic Neurons, which are the main type of cells affected in PD. The reduced insulin media did not change the ability of these neurons to develop, which was promising.
Results of Insulin Testing
When researchers analyzed the mini-brains, they found that high insulin levels caused problems. The cells in the high insulin environment had less of a specific protein that helps with insulin signaling, indicating they were not responding well to insulin. On the other hand, the mini-brains exposed to lower insulin levels had more of this protein, showing they were still sensitive to insulin.
When they added insulin to stimulate these cells, they found that the mini-brains with high insulin did not respond properly. They had less electrical activity, produced less dopamine, and had fewer dopaminergic neurons compared to those that were exposed to lower insulin levels.
The Impact of Insulin Sensitivity
Next, the researchers wanted to see if insulin sensitivity (being responsive to insulin) could improve the health of dopaminergic neurons. While they didn't see a difference in neuron numbers after 30 days, they noticed that after 60 days, the mini-brains with lower insulin levels had a significantly higher number of dopaminergic neurons. This increase was also linked to more dopamine production, which is vital for movement and coordination.
They measured the electrical activity in these mini-brains and found that those cultured with lower insulin levels had a higher rate of electrical firing, indicating increased activity. This included more synchronized bursts of activity, which is a sign of healthy brain function.
Exploring Metabolism Changes in Insulin Resistance
To further understand how insulin resistance affects metabolism, the researchers created metabolic models based on the genetic activity within the mini-brains. They looked for differences in metabolic pathways between those with high insulin and those with lower insulin. The analysis revealed that insulin resistance affected lipid metabolism and how efficiently cells used glucose for energy.
They found that the mini-brains with insulin resistance had higher levels of certain lipids, or fats, which may connect to neurodegenerative conditions. Specifically, researchers observed an increase in cholesterol esters, which have been linked to brain diseases.
In contrast, the mini-brains with lower insulin levels had a healthier lipid profile, indicating that they maintained better overall brain health.
Specific Findings on Energy Production
Through their experiments, the researchers discovered that insulin resistance led to less efficient energy production. Mini-brains with high insulin levels showed a reliance on fatty acid oxidation for energy. This can be harmful over time, as it could lead to toxic byproducts.
In contrast, those with lower insulin levels were more efficient at using glucose, which is essential for healthy brain function. They also checked the levels of energy molecules in the cells and found that those cultured under lower insulin conditions had higher energy levels, confirming that they were healthier.
Conclusion: The Link Between Insulin Resistance and Parkinson’s Disease
This study sheds light on how insulin resistance might play a crucial role in the development of Parkinson’s disease. By using mini-brain models, researchers were able to observe direct effects of insulin levels on neuron health and function. Higher insulin levels led to reduced neuron numbers and activity, which mirrors what happens in many individuals with T2D and PD.
Understanding this link can help in developing strategies to prevent or slow down the progression of PD, especially for those at risk due to diabetes. Further research is needed to explore these relationships in greater detail, potentially opening up new avenues for treatment and prevention in the future.
Implications for Future Research
The findings indicate that managing insulin levels and improving insulin sensitivity could be beneficial for brain health. Researchers highlight the importance of lifestyle changes, such as diet and exercise, which can improve insulin sensitivity and may also positively influence brain function in people with or at risk for PD.
Moreover, the use of mini-brain organoids offers a powerful tool for studying brain diseases. This model can be used to test various treatments and understand the mechanisms underlying neurodegenerative diseases.
Final Thoughts
As the population ages and more people are diagnosed with diabetes, understanding the interconnectedness of these conditions becomes increasingly important. This research offers promising insights into potential preventive measures and therapies that could alter the course of neurodegenerative diseases like Parkinson’s.
By continuing to study how insulin affects brain health, researchers hope to uncover further links that could lead to improved outcomes for those affected by these diseases. The ultimate goal is to foster better brain health through improved management of metabolic conditions, ensuring that individuals can maintain their quality of life as they age.
Title: Insulin resistance compromises midbrain organoid neural activity and metabolic efficiency predisposing to Parkinsons disease pathology
Abstract: Growing evidence indicates that Type 2 Diabetes (T2D) is associated with an increased risk of developing Parkinsons disease through shared disease mechanisms. Studies show that insulin resistance, which is the driving pathophysiological mechanism of T2D plays a major role in neurodegeneration by impairing neuronal functionality, metabolism, and survival. To investigate insulin resistance caused pathological changes in the human midbrain, which could predispose a healthy midbrain to PD development, we exposed iPSC-derived human midbrain organoids from healthy individuals to either high insulin concentrations, promoting insulin resistance, or to more physiological insulin concentrations restoring insulin signalling function. We combined experimental methods with metabolic modelling to identify the most insulin resistance-dependent pathogenic processes. We demonstrate that insulin resistance compromises organoid metabolic efficiency, leading to increased levels of oxidative stress. Additionally, insulin-resistant midbrain organoids showed decreased neural activity and reduced amount of dopaminergic neurons, highlighting insulin resistance as a significant target in PD prevention.
Authors: Jens Christian Schwamborn, A. Zagare, J. Kurlovics, C. Almeida, D. Ferrante, D. Frangenberg, L. Neises, A. Vitali, G. Gomez-Giro, C. Jaeger, P. Antony, R. Halder, R. Krueger, E. Glaab, J. Meiser, E. Stalidzans, G. Arena
Last Update: 2024-05-05 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.05.03.592331
Source PDF: https://www.biorxiv.org/content/10.1101/2024.05.03.592331.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.